Duration: 2-4 weeks intensive phase, followed by 4-8 weeks standard protocol
INTRODUCTION Obesity is a major public health problem around the world that is linked to severe comorbid disease conditions, physical impairment, high mortality rates, and compromised quality of life.[14] Obesity is characterized by the buildup of excessive body fat and extreme dysregulation in whole-body energy expenditure, glucose, hormone, and lipid homeostasis that typically present as adverse metabolic disorders.[4, 5] Additionally, the physiological, metabolic, and psychological changes that accompany obesity are major factors in the development of type 2 diabetes (T2D), cardiovascular disease (CVD) (e.g., coronary heart disease, dyslipidemia, hypertension),[6, 7] stroke, inflammation, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), osteoarthritis, sleep apnea, and several obesity-linked cancers (e.g., colorectal, breast, kidney, prostate).[6, 8] Lifestyle modifications including diet and exercise may help reverse obesity and improve chronic disease biomarkers (e.g., T2D),[9] but are largely ineffective in achieving sustained weight loss and glycemic control.[10] Pharmacological treatments for obesity exist, but unfortunately most approved anti-obesity drugs have only modest efficacy and/or produce severe adverse effects (e.g., cardiovascular risks, central nervous system effects)
Our team helps you develop the behaviors that will boost the effects of peptide therapy in Green Bay & Barrington
BPC-157 / TB-500 Blend Research Peptide Supplied in Thailand BPC-157 / TB-500 Blend is a dual-peptide research compound supplied as a high-purity lyophilised powder (HPLC/MS verified)
Water solubility Water solubility is an important parameter, which gives information on the polarity of the molecule and its capacity to be extracted by an aqueous solvent or to form hydrogen bond interactions
